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Abst ract
Background and purpose: Ischaemic stroke is considered to
be multifactorial and interactions between environmental and
genetic factors play an important role. Although vascular risk
factors are well known, the genetic ones are still undiscover -
ed. In the present study, we assessed the significance of the
β-fibrinogen –455G/A gene polymorphism and the risk of
ischaemic stroke in a Polish population.
Material and methods: 426 ischaemic stroke patients classi-
fied according to stroke aetiologies (small vessel disease, large
vessel disease or cardioembolic stroke) and 234 controls were
included in the study. The association of the β-fibrinogen
genotypes with ischaemic stroke was tested using logistic
regression analysis under dominant, recessive or additive
models of inheritance. 
Results: The allele and genotype distributions of the β-fibri -
nogen –455G/A gene polymorphism did not differ signifi-
cantly between patients and controls (patients: G – 75%, 
GG – 56.6%, GA – 36.8%, AA – 6.6%; controls: G – 73.7%,
GG – 57.3%, GA – 32.9%, AA – 9.8%; p > 0.05, χ2). In
addition, logistic regression analysis adjusted for the known
risk factors, i.e. hypertension, ischaemic heart disease, myocar-
dial infarction, hypercholesterolaemia, diabetes mellitus and
smoking, did not show a role of the studied polymorphism
in ischaemic stroke.
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Wstêp i cel pracy: Etiologia udaru niedokrwiennego mózgu
jest wieloczynnikowa. Istotn¹ rolê odgrywaj¹ w niej inter akcje
pomiêdzy czynnikami œrodowiskowymi i genetycznymi. Na -
czyniowe czynniki ryzyka udaru mózgu s¹ doœæ dobrze po -
znane, natomiast rola czynników genetycznych pozostaje
wci¹¿ niejasna. W prezentowanym badaniu oceniano zna-
czenie polimorfizmu –455G/A genu β-fibrynogenu w kon-
tekœcie ryzyka wyst¹pienia udaru niedokrwiennego mózgu
w populacji polskiej. 
Materia³ i metody: Do badania w³¹czono 426 chorych na udar
niedokrwienny mózgu sklasyfikowanych zgodnie z etiologi¹
udaru (choroba ma³ych naczyñ, choroba du¿ych naczyñ lub
udar sercowozatorowy) oraz 234 osoby z grupy kontrolnej.
Zwi¹zek pomiêdzy badanym polimorfizmem a udarem nie-
dokrwiennym mózgu zosta³ zbadany przy u¿yciu regresji logi-
stycznej w dominuj¹cym, recesywnym i addytywnym mode-
lu dziedziczenia. 
Wyniki: Nie stwierdzono istotnej ró¿nicy w rozk³adzie alleli
i genotypów polimorfizmu –455G/A genu β-fibrynogenu po -
miêdzy pacjentami a osobami z grupy kontrolnej (pacjenci:
G – 75%, GG – 56,6%, GA – 36,8%, AA – 6,6%; grupa kon-
trolna: G – 73,7%, GG – 57,3%, GA – 32,9%, AA – 9,8 %;
p > 0,05, test χ2). Ponadto w modelu regresji logistycznej
uwzglêdniaj¹cym wp³yw znanych czynników ryzyka, takich
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Introduction 
Ischaemic stroke is one of the leading causes of dis-
ability and death in the developed countries [1]. Apart
from the known risk factors, such as older age, hyper-
tension, atrial fibrillation, diabetes mellitus, smoking or
positive family history, there are data showing that gene-
tic factors may play a role in the risk of ischaemic stroke,
but they are not thoroughly investigated [2]. It is well
known that plasma fibrinogen levels are regarded as an
independent risk factor for overall ischaemic stroke, as
well as for all main etiological subtypes [3]. Moreover,
it is proved that fibrinogen levels are significantly high-
er in large vessel and cardioembolic strokes as compared
to small vessel or cryptogenic strokes [3]. There are sev-
e ral factors that could affect plasma fibrinogen concen-
trations [4,5]. Among them, the A allele of the β-fib-
rinogen –455G/A gene single nucleotide polymorphism
(SNP) (rs 1800790) is mentioned [4]. It was shown
that the A allele of this SNP is associated with high plas-
ma fibrinogen levels [4].
In the present study we investigated the relationship
between the –455G/A SNP in the β-fibrinogen gene
and ischaemic stroke risk in a Polish population.
Material and methods
Consecutive patients with ischaemic stroke, admit-
ted to the Stroke Unit, Department of Neurology, Uni-
versity Hospital in Krakow, Poland, between 2008 and
2010, participated in the study. During hospitalization,
patients underwent neuroimaging, ECG, carotid ultra-
sound and echocardiography. A standardized question-
naire on demographics, medical history and vascular
risk factors, i.e. hypertension, ischaemic heart disease,
myocardial infarction, hypercholesterolaemia, diabetes
mellitus and smoking, were taken from all participants.
Stroke aetiology was established according to the TOAST
criteria [6]. Only patients with known stroke aetiology
were included in the study. Control individuals were
recruited from relatives of the hospital staff, consecutive
spouses of the patients of the Department of Neurolo-
gy, or from the community. They had no medical histo-
ry of neurological disorders. All subjects were Caucasian
and gave informed consent. The study was approved by
the local ethics committee.
Genomic DNA was extracted from peripheral blood
using a commercially available kit (Boehringer Mann -
heim, Germany). The β-fibrinogen –455G/A gene SNP
was detected by polymerase chain reaction and restric-
tion enzyme digestion, as described previously [7].
Comparisons between the groups were studied using
χ2 test or Student’s t-test. The Hardy-Weinberg equi-
librium was tested by χ2 test. The association of the 
β-fibrinogen genotypes with ischaemic stroke was test-
ed using logistic regression analysis under dominant 
(AA + GA vs. GG), recessive (AA vs. GA + GG) or
additive (AA vs. GA vs. GG) models of inheritance.
A p-value less than 0.05 was considered significant.
Results
Altogether 426 patients with ischaemic stroke out of
all 554 ischaemic stroke victims and 234 controls were
included in the study. Stroke aetiology was not established
in 128 patients. There was no deviation from the Hardy-
Weinberg equilibrium regarding the β-fibrinogen –
455G/A gene SNP in the studied groups (p > 0.05).
The demographic characteristics and stroke risk factor
profile are summarized in Table 1. Out of the 426 pa -
tients, 28.4% (n = 121) had small vessel disease, 23%
(n = 98) had large vessel disease and 48.6% (n = 207)
had cardioembolic stroke.
The allele and genotype distributions were similar
between patients and controls (patients: G – 75%, GG –
56.6%, GA – 36.8%, AA – 6.6%; controls: G – 73.7%,
GG – 57.3%, GA – 32.9%, AA – 9.8 %; p > 0.05, 
χ2 test). Moreover, the frequency of alleles and geno-
Conclusions: The β-fibrinogen –455G/A gene polymorphism
is not a risk factor for ischaemic stroke in a Polish population.
Key words: ischaemic stroke, fibrinogen, single nucleotide
polymorphism.
jak: nadciœnienie têtnicze, choroba niedokrwienna serca, zawa³
miêœnia sercowego, hipercholesterolemia, cukrzyca i palenie
tytoniu, nie wykazano roli badanego polimorfizmu w udarze
niedokrwiennym mózgu.
Wnioski: Polimorfizm –455G/A genu β-fibrynogenu nie jest
czynnikiem ryzyka udaru niedokrwiennego mózgu w popu-
lacji polskiej.
S³owa kluczowe: udar niedokrwienny mózgu, fibrynogen,
polimorfizm.
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types between patients with small vessel disease, large
vessel disease or cardioembolic stroke and controls did
not differ significantly (Table 2). In addition, logistic
regression analysis both crude and adjusted (for hyper-
tension, ischaemic heart disease, cardiac infarction, hyper-
cholesterolaemia, diabetes mellitus and smoking) did
not show the significance of the β-fibrinogen –455G/A
gene SNP as a risk factor for ischaemic stroke, irre-
spectively of its aetiologies under dominant, recessive or
additive models of inheritance (Table 3). 
Discussion
We failed to find any relationship between the β-fi bri -
nogen –455G/A gene SNP and ischaemic stroke in
a Polish population. Moreover, logistic regression analy-
sis adjusted for the known risk factors did not show the
significance of the studied polymorphism as a risk fac-
tor for ischaemic stroke. 
In the first positive study, 227 patients with cere-
brovascular diseases (185 patients had ischaemic stroke
and 42 had transient ischaemic attack or reversible
ischaemic neurological deficit) and 225 controls were
included. This study showed an association between the
AA genotype and large vessel disease stroke (χ2 = 4.0,
p = 0.045) [8]. There were a few more reports show-
ing a positive association between the genotype with the
A allele and specific ischaemic stroke subgroups, for
example in males compared to elderly male controls 
(OR = 3.84, 95% CI: 1.64-9.02; p < 0.02) [9] or in
single lacunar stroke as compared to recurrent lacunar
strokes (three or more) (OR = 2.72, 95% CI: 1.18-6.27;
p = 0.02) [7]. Additionally, hypertensive patients car-
rying the genotype with the A allele had more than four-
Patients Controls Odds 95% confidence P-value
(n = 426) (n = 234) ratio* interval*
Age [years], mean (SD) 67.2 (13.3) 67.61 (12.17) 1.00 0.99-1.01 0.87
Male, % 49.3 44.0 0.81 0.59-1.12 0.21
Hypertension, % 81.7 56.8 3.64 2.52-5.26 < 0.001
Ischaemic heart disease, % 54.7 40.7 1.98 1.39-2.80 < 0.001
Myocardial infarction, % 15.0 6.4 2.51 1.39-4.54 0.002
Hypercholesterolaemia, % 55.4 35.8 2.40 1.66-3.47 < 0.001
Diabetes mellitus, % 21.6 14.2 1.71 1.10-2.66 0.017
Smokers, % 33.8 18.0 2.31 1.51-3.54 < 0.001
Table 1. Demographic characteristics and risk factor profile of the study subjects
*Logistic regression analysis adjusted for age and gender
SD – standard deviation
Small vessel Large vessel Cardioembolic Controls
disease disease stroke (n = 234)
(n = 121) (n = 98) (n = 207)
Genotypes, n (%)
GG 73 (60.3)* 56 (57.1)* 112 (54.1)* 134 (57.3)
GA 40 (33.1)* 38 (38.8)* 79 (38.2)* 77 (32.9)
AA 8 (6.6)* 4 (4.1)* 16 (7.7)* 23 (9.8)
Alleles, n (%)
G 186 (76.9)* 150 (76.5)* 303 (73.2)* 345 (73.7)
A 56 (23.1)* 46 (23.5)* 111 (26.8)* 123 (26.3)
Table 2. Genotype and allele distributions in controls and patients classified according to stroke aetiologies 
*Stroke subgroups vs. controls, χ2 test, p > 0.05
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fold risk for recurrent lacunar strokes compared with
patients carrying the GG genotype without hyperten-
sion (OR = 4.24, 95% CI: 1.29-13.99; p = 0.02) [7].
On the other hand, the role of the A allele of the β-fib-
rinogen –455G/A gene SNP in ischaemic stroke was
not confirmed in Hungarian [10], Dutch [12], or Ko -
rean populations [11]. 
It is difficult to compare the present results with pre-
viously published studies, since two of the six quoted
studies had no control groups [7,11], only three research
groups took into consideration different stroke aetiolo-
gies [7,8,11] and, in addition, the number of subjects
included in all studies was relatively small [7-12]; the most
numerous group consisted of 299 stroke cases [7]. Fi nal-
 ly, the ethnicity of subjects who participated in two out
of the six studies were other than Caucasian [9,11]. 
Briefly, only a meta-analysis of all published results
would increase the power of the study and could find
a true association between the β-fibrinogen –455G/A
gene SNP and ischaemic stroke. However, in relation to
the differences in homogeneity between the studied con-
trols (only females or patients with recurrent strokes)
[7,12] it would be difficult to conduct it. Thus, the ge -
netic case-control association studies should be designed
and performed using similar patterns accepted by all
researchers.
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